Case file · CIK 0001009258
Healthcare and biotech specialist capital sample.
Q4 2025 · SEC 13F case file
KOL-style case note
Healthcare and biotech specialist capital sample. This page turns the latest public filing into a shareable research story: what the entity owns, which theme is driving the portfolio, and where to investigate next.
Healthcare and biotech specialist capital sample. It belongs in a smart-money radar because its public 13F shows quarterly capital direction and theme preference.
The latest filing's largest public position is NUVL, around 22.2% of the disclosed 13F portfolio. That is the first place to look for the current thesis.
Mixed is the clearest public theme in the portfolio. The important question is whether that theme repeats across the top positions, not just whether one stock worked.
The latest public portfolio is about $7.8B, with 150 lines and roughly 52.3% in the top 10. Higher concentration means a few decisions can explain more of the proxy return.
This is not a live trading signal. It is a quarterly capital map: start with the ranking, inspect the top holdings, then ask whether the manager has a repeatable framework.
13F filings are delayed and incomplete. They do not show shorts, many derivatives, private positions, cash, or current trade timing. Use this page to generate research questions, not to replace diligence.
Smart Money VelocityVelocity score blends 13F value growth, concentration, theme purity, option exposure, and filing history. It is a prioritization score, not a return.
Score blends filing growth, concentration, theme purity, call exposure, and filing history.
13F value
$7.8BQ4 2025, latest public filingGrowth since first filing
1.75x$4.5B → $7.8BReporting lag13F filings arrive after the quarter ends. The page shows a delayed public snapshot, not live positions.
45dQuarter-end snapshot, not live positionsThis is not actual fund performance. Returns and rankings use public disclosures after they become visible, not private NAV or live trading.
Disclosure workflow
Every number is anchored to a public quarterly filing. The report date is the portfolio snapshot; the filing date is when the market could actually see it.
Public holdings
| Holding | Theme | Type | Value | % |
|---|---|---|---|---|
| NUVALENT INCNUVL · 17,248,450 shares | Other | SH | $1.7B | 22.2% |
| BROOKDALE SR LIVING INC112463AF1 · 306,885,000 shares | Other | PRN | $427.5M | 5.5% |
| COGENT BIOSCIENCES INCCOGT · 9,043,903 shares | Other | SH | $321.2M | 4.1% |
| PRAXIS PRECISION MEDICINES IPRAX · 903,351 shares | Other | SH | $266.3M | 3.4% |
| CENTENE CORP DELCNC · 6,447,998 shares | Other | SH | $265.3M | 3.4% |
| VIATRIS INCVTRS · 20,206,170 shares | Other | SH | $251.6M | 3.2% |
| REVOLUTION MEDICINES INCRVMD · 2,894,613 shares | Other | SH | $230.6M | 2.9% |
| UNITED THERAPEUTICS CORP DELUTHR · 425,993 shares | Other | SH | $207.6M | 2.7% |
| VERA THERAPEUTICS INCVERA · 4,059,695 shares | Other | SH | $205.6M | 2.6% |
| MIRUM PHARMACEUTICALS INC604749AB7 · 70,000,000 shares | Semis | PRN | $180.7M | 2.3% |
| CELCUITY INCCELC · 1,714,000 shares | Other | SH | $171M | 2.2% |
| NEUROCRINE BIOSCIENCES INCNBIX · 1,184,345 shares | Other | SH | $168M | 2.1% |
| IONIS PHARMACEUTICALS INCIONS · 1,979,669 shares | Semis | SH | $156.6M | 2.0% |
| NEWAMSTERDAM PHARMA COMPANYNAMS · 4,164,789 shares | Semis | SH | $146.1M | 1.9% |
| INSPIRE MED SYS INC457730109 · 1,505,872 shares | Other | SH | $138.9M | 1.8% |
| LEGEND BIOTECH CORPLEGN · 5,932,000 shares | Other | SH | $129M | 1.6% |
| BROOKDALE SR LIVING INC112463104 · 11,637,032 shares | Other | SH | $125.6M | 1.6% |
| INDIVIOR PLCINDV · 3,393,063 shares | Other | SH | $121.7M | 1.6% |
| ARROWHEAD PHARMACEUTICALS INARWR · 1,832,946 shares | Semis | SH | $121.7M | 1.6% |
| LARIMAR THERAPEUTICS INCLRMR · 30,606,974 shares | Other | SH | $116.6M | 1.5% |
| CATALYST PHARMACEUTICALS INCCPRX · 4,911,161 shares | Semis | SH | $114.6M | 1.5% |
| ADAPTHEALTH CORPAHCO · 11,477,730 shares | Other | SH | $114.3M | 1.5% |
| BIOCRYST PHARMACEUTICALS INCBCRX · 14,341,000 shares | Semis | SH | $111.9M | 1.4% |
| IONIS PHARMACEUTICALS INC462222AF7 · 60,000,000 shares | Semis | PRN | $95.3M | 1.2% |
| ALIGNMENT HEALTHCARE INC01625VAB0 · 61,000,000 shares | Other | PRN | $92.6M | 1.2% |
| ARS PHARMACEUTICALS INCSPRY · 7,503,812 shares | Semis | SH | $87.4M | 1.1% |
| PHARVARIS N VPHVS · 3,126,042 shares | Other | SH | $86.7M | 1.1% |
| SAVARA INCSVRA · 13,569,000 shares | Other | SH | $81.8M | 1.0% |
| IDEAYA BIOSCIENCES INCIDYA · 2,153,043 shares | Other | SH | $74.4M | 0.95% |
| CERTARA INCCERT · 7,808,605 shares | Other | SH | $68.8M | 0.88% |
| BIO RAD LABS INC090572207 · 226,070 shares | Other | SH | $68.5M | 0.87% |
| NEOGENOMICS INC64049MAB6 · 72,689,000 shares | Other | PRN | $64.7M | 0.83% |
| ACADIA HEALTHCARE COMPANY INACHC · 4,520,000 shares | Other | SH | $64.1M | 0.82% |
| BRIDGEBIO ONCOLOGY THERAPEUTBBOT · 4,885,446 shares | Other | SH | $61.2M | 0.78% |
| STOKE THERAPEUTICS INCSTOK · 1,823,500 shares | Other | SH | $57.9M | 0.74% |
| LANTHEUS HLDGS INCLNTH · 827,999 shares | Other | SH | $55.1M | 0.70% |
| STRUCTURE THERAPEUTICS INCGPCR · 767,993 shares | Other | SH | $53.4M | 0.68% |
| ENVISTA HOLDINGS CORPORATIONNVST · 2,280,498 shares | Other | SH | $49.5M | 0.63% |
| ENHABIT INCEHAB · 4,747,746 shares | Other | SH | $43.8M | 0.56% |
| KYMERA THERAPEUTICS INCKYMR · 561,170 shares | Other | SH | $43.7M | 0.56% |
| CAREDX INCCDNA · 2,191,000 shares | Other | SH | $41.3M | 0.53% |
| DISC MEDICINE INCIRON · 511,163 shares | Other | SH | $40.6M | 0.52% |
| SIONNA THERAPEUTICS INCSION · 970,590 shares | Other | SH | $39.9M | 0.51% |
| LIVANOVA PLC53802LAB8 · 34,280,000 shares | Other | PRN | $39.7M | 0.51% |
| BELITE BIO INCBLTE · 233,813 shares | Other | SH | $37.4M | 0.48% |
| DAY ONE BIOPHARMACEUTICALS I23954D109 · 3,723,131 shares | Semis | SH | $34.7M | 0.44% |
| PHREESIA INCPHR · 1,999,045 shares | Other | SH | $33.8M | 0.43% |
| EMBECTA CORPEMBC · 2,752,031 shares | Other | SH | $32.7M | 0.42% |
| VERACYTE INCVCYT · 726,000 shares | Other | SH | $30.6M | 0.39% |
| MODERNA INCMRNA · 1,000,000 underlying shares | Hedge | PUT | $29.5M | 0.38% |
| LANTHEUS HLDGS INC516544AB9 · 25,255,000 shares | Other | PRN | $28.9M | 0.37% |
| BETA BIONICS INCBBNX · 938,308 shares | Other | SH | $28.6M | 0.37% |
| VENTAS INCVTR · 354,000 shares | Other | SH | $27.4M | 0.35% |
| IMMUNOCORE HLDGS PLC45258DAB1 · 30,000,000 shares | Other | PRN | $27.1M | 0.35% |
| ALNYLAM PHARMACEUTICALS INCALNY · 67,935 shares | Semis | SH | $27M | 0.35% |
| TANGO THERAPEUTICS INCTNGX · 2,906,946 shares | Other | SH | $25.8M | 0.33% |
| XENON PHARMACEUTICALS INCXENE · 542,020 shares | Semis | SH | $24.3M | 0.31% |
| SPYRE THERAPEUTICS INCSYRE · 710,626 shares | Other | SH | $23.3M | 0.30% |
| FOGHORN THERAPEUTICS INCFHTX · 3,649,211 shares | Other | SH | $19.7M | 0.25% |
| COMPASS THERAPEUTICS INCCMPX · 3,606,000 shares | Other | SH | $19.4M | 0.25% |
| EDGEWISE THERAPEUTICS INCEWTX · 765,694 shares | Other | SH | $19M | 0.24% |
| KYVERNA THERAPEUTICS INCKYTX · 2,000,000 shares | Other | SH | $18.8M | 0.24% |
| TAYSHA GENE THERAPIES INCTSHA · 2,722,165 shares | Other | SH | $15M | 0.19% |
| CORMEDIX INCCRMD · 1,107,944 shares | Other | SH | $12.9M | 0.16% |
| THE ONCOLOGY INSTITUTE INCTOI · 3,360,052 shares | Other | SH | $12M | 0.15% |
| MONOPAR THERAPEUTICS INCMNPR · 170,558 shares | Other | SH | $11.1M | 0.14% |
| MEDLINE INCMDLN · 260,000 shares | Other | SH | $10.9M | 0.14% |
| OMADA HEALTH INCOMDA · 553,107 shares | Other | SH | $8.7M | 0.11% |
| CALCIMEDICA INCCALC · 1,300,000 shares | Other | SH | $8.6M | 0.11% |
| PRESTIGE CONSMR HEALTHCARE I74112D101 · 69,669 shares | Other | SH | $4.3M | 0.05% |
| CULLINAN THERAPEUTICS INCCGEM · 386,169 shares | Other | SH | $4M | 0.05% |
| VEEVA SYS INCVEEV · 17,711 shares | Other | SH | $4M | 0.05% |
| RADNET INCRDNT · 49,951 shares | Other | SH | $3.6M | 0.05% |
| LABCORP HOLDINGS INCLH · 13,825 shares | Other | SH | $3.5M | 0.04% |
| ENOVIS CORPORATIONENOV · 127,270 shares | Other | SH | $3.4M | 0.04% |
| ALIGNMENT HEALTHCARE INCALHC · 164,345 shares | Other | SH | $3.2M | 0.04% |
| QUEST DIAGNOSTICS INCDGX · 18,392 shares | Other | SH | $3.2M | 0.04% |
| TRANSMEDICS GROUP INCTMDX · 25,492 shares | Other | SH | $3.1M | 0.04% |
| INSULET CORPPODD · 10,616 shares | Other | SH | $3M | 0.04% |
| ANNEXON INCANNX · 583,913 shares | Other | SH | $2.9M | 0.04% |
| BIOLIFE SOLUTIONS INCBLFS · 120,211 shares | Other | SH | $2.9M | 0.04% |
| CHEMED CORP NEWCHE · 6,215 shares | Other | SH | $2.7M | 0.03% |
| PETCO HEALTH & WELLNESS CO IWOOF · 936,309 shares | Other | SH | $2.6M | 0.03% |
| ORTHOPEDIATRICS CORPKIDS · 144,220 shares | Other | SH | $2.6M | 0.03% |
| THE CIGNA GROUPCI · 9,203 shares | Other | SH | $2.5M | 0.03% |
| TRUPANION INCTRUP · 66,438 shares | Other | SH | $2.5M | 0.03% |
| RESMED INCRMD · 10,104 shares | Other | SH | $2.4M | 0.03% |
| BOSTON SCIENTIFIC CORPBSX · 24,941 shares | Other | SH | $2.4M | 0.03% |
| DAVITA INCDVA · 20,909 shares | Other | SH | $2.4M | 0.03% |
| DOXIMITY INCDOCS · 51,942 shares | Other | SH | $2.3M | 0.03% |
| DEXCOM INCDXCM · 32,943 shares | Other | SH | $2.2M | 0.03% |
| IRHYTHM TECHNOLOGIES INCIRTC · 12,099 shares | Other | SH | $2.1M | 0.03% |
| NEWAMSTERDAM PHARMA COMPANYNAMS · 92,787 shares | Semis | SH | $2.1M | 0.03% |
| CONMED CORPCNMD · 52,555 shares | Other | SH | $2.1M | 0.03% |
| MASIMO CORPMASI · 16,147 shares | Other | SH | $2.1M | 0.03% |
| LEMAITRE VASCULAR INCLMAT · 25,815 shares | Other | SH | $2.1M | 0.03% |
| 10X GENOMICS INCTXG · 126,574 shares | Other | SH | $2.1M | 0.03% |
| ATRICURE INCATRC · 52,076 shares | Other | SH | $2.1M | 0.03% |
| AVANOS MED INCAVNS · 167,061 shares | Other | SH | $1.9M | 0.02% |
| CORVEL CORPCRVL · 27,629 shares | Other | SH | $1.9M | 0.02% |
| CARDINAL HEALTH INCCAH · 8,985 shares | Other | SH | $1.8M | 0.02% |
| GOODRX HLDGS INCGDRX · 660,133 shares | Other | SH | $1.8M | 0.02% |
| SURGERY PARTNERS INCSGRY · 112,623 shares | Other | SH | $1.7M | 0.02% |
| ALIGN TECHNOLOGY INCALGN · 11,000 shares | Other | SH | $1.7M | 0.02% |
| ADDUS HOMECARE CORPADUS · 15,871 shares | Other | SH | $1.7M | 0.02% |
| MERIT MED SYS INC589889104 · 18,798 shares | Other | SH | $1.7M | 0.02% |
| NATIONAL HEALTHCARE CORPNHC · 12,085 shares | Other | SH | $1.7M | 0.02% |
| ALECTOR INCALEC · 1,055,192 shares | Other | SH | $1.6M | 0.02% |
| ENCOMPASS HEALTH CORPEHC · 15,259 shares | Other | SH | $1.6M | 0.02% |
| VAREX IMAGING CORPVREX · 131,745 shares | Other | SH | $1.5M | 0.02% |
| HEALTHEQUITY INCHQY · 16,231 shares | Other | SH | $1.5M | 0.02% |
| ABBOTT LABSABT · 11,449 shares | Other | SH | $1.4M | 0.02% |
| MAXIMUS INCMMS · 16,606 shares | Other | SH | $1.4M | 0.02% |
| STRYKER CORPORATIONSYK · 3,551 shares | Other | SH | $1.2M | 0.02% |
| ALPHATEC HLDGS INCATEC · 57,277 shares | Other | SH | $1.2M | 0.02% |
| STAAR SURGICAL COSTAA · 51,894 shares | Other | SH | $1.2M | 0.02% |
| EDWARDS LIFESCIENCES CORPEW · 13,702 shares | Other | SH | $1.2M | 0.01% |
| UFP TECHNOLOGIES INCUFPT · 5,098 shares | Other | SH | $1.1M | 0.01% |
| KENVUE INCKVUE · 65,344 shares | Other | SH | $1.1M | 0.01% |
| MIMEDX GROUP INCMDXG · 160,419 shares | Other | SH | $1.1M | 0.01% |
| INTEGER HLDGS CORPITGR · 13,326 shares | Other | SH | $1M | 0.01% |
| REVVITY INCRVTY · 10,323 shares | Other | SH | $998.8K | 0.01% |
| AZENTA INCAZTA · 25,835 shares | Other | SH | $859.3K | 0.01% |
| ARVINAS INCARVN · 68,057 shares | Other | SH | $807.2K | 0.01% |
| ZOETIS INCZTS · 5,698 shares | Other | SH | $716.9K | 0.01% |
| COOPER COS INC216648501 · 7,786 shares | Other | SH | $638.1K | 0.01% |
| SCHRODINGER INCSDGR · 33,987 shares | Other | SH | $607.7K | 0.01% |
| TANDEM DIABETES CARE INCTNDM · 26,090 shares | Other | SH | $573.5K | 0.01% |
| RXSIGHT INCRXST · 52,257 shares | Other | SH | $544.5K | 0.01% |
| INTEGRA LIFESCIENCES HLDGS CIART · 39,209 shares | Other | SH | $487K | 0.01% |
| ABBVIE INCABBV · 2,014 shares | Other | SH | $460.2K | 0.01% |
| HARROW INCHROW · 8,693 shares | Other | SH | $426K | 0.01% |
| XERIS BIOPHARMA HOLDINGS INCXERS · 52,230 shares | Semis | SH | $410K | 0.01% |
| HEALTHCARE SVCS GROUP INC421906108 · 21,259 shares | Other | SH | $406.5K | 0.01% |
| AMPHASTAR PHARMACEUTICALS INAMPH · 14,852 shares | Semis | SH | $397.7K | 0.01% |
| REPLIGEN CORPRGEN · 2,199 shares | Other | SH | $360.3K | 0.00% |
| STERIS PLCSTE · 1,352 shares | Other | SH | $342.8K | 0.00% |
| BELLRING BRANDS INCBRBR · 11,996 shares | Other | SH | $320.7K | 0.00% |
| INTUITIVE SURGICAL INCISRG · 483 shares | Other | SH | $273.6K | 0.00% |
| NATIONAL VISION HLDGS INCEYE · 10,284 shares | Other | SH | $265.5K | 0.00% |
| BIOMX INCPHGE · 131,270 shares | Other | SH | $245.5K | 0.00% |
| HUMANA INCHUM · 917 shares | Other | SH | $234.9K | 0.00% |
| ABEONA THERAPEUTICS INCABEO · 40,000 shares | Other | SH | $210.8K | 0.00% |
| THE ONCOLOGY INSTITUTE INCTOI · 1,250,000 shares | Other | SH | $150.6K | 0.00% |
| QUANTUM SI INCQSI · 333,333 shares | Other | SH | $66.8K | 0.00% |
| NUVATION BIO INCNUVB · 166,666 shares | Other | SH | $55K | 0.00% |
| BUTTERFLY NETWORK INCBFLY · 733,333 shares | Other | SH | $12.9K | 0.00% |
| PMV PHARMACEUTICALS INCPMVP · 8,790 shares | Semis | SH | $11K | 0.00% |
| SURROZEN INCSRZN · 166,666 shares | Other | SH | $3.3K | 0.00% |
| MYRIAD GENETICS INCMYGN · 505 shares | Other | SH | $3.1K | 0.00% |
Quarter tape
Signal breakdown
13F value is 1.75x the first tracked filing.
Top ten public lines are 52.3% of the latest report.
150 reportable lines in the latest public filing.
12 tracked quarterly 13F reports in the database or seed layer.
Publisher mode
Evidence layer
13F reports disclose long reportable U.S. securities and long put/call options. They do not show cash, private stakes, shorts, written options, or current live holdings.
Theme tags are deterministic product analysis from issuer, CUSIP, option type, and keyword rules. They are not SEC labels.
Vercel Cron calls the EDGAR ingestion endpoint every day and records per-manager ingestion results.
